OMN-54

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameOMN-54
Drug Alias NameAneustatOMN-54
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionPregnane X receptor agonistsAdenosine receptor agonistsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Pregnane X receptorAdenosine receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenyous Biomed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOmnitura Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A